| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP, SGS |
| Suitable for: | Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
| Name | Sonwu Supply CAS 220127-57-1 Powder Imatinib Mesylate |
| CAS NO. | 220127-57-1 |
| Molecular Formula | C30h35n7o4s |
| MW | 589.71 |
| Purity | 99% |
| Appearanc | White powder |
| Certificate | ISO, SGS, GMP, HACCP |
| MOQ | 10 g |
| Shelf life | 2 Years |
Cells were stimulated with allogeneic mature DCs or PHA in the presence of imatinib mesylate. The drug inhibited T-cell proliferation as a function of concentration. The effects were significant at 0.5 μM imatinib mesylate for the cells stimulated by DCs and at 1.0 μM imatinib mesylate for the cells stimulated with PHA. The IC50 values for imatinib mesylate-inhibited T-cell proliferation stimulated by DCs and PHA were 3.9 μM and 2.9 μM, respectively..
A tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL).Imatinib Mesylate is orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib also known as Gleevec, Glivec, CGP-57148B, STI-571 & Imatinib.
Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively.Echinocandin antifungal, active against infections with Aspergillus and Candida, inhibits cell wall synthesis
1. It may be continued as long as there is no evidence of progressive disease or unacceptable toxicity.
2. Imatinib Dosage:
The prescribed dose should be administered orally, with a meal and a large glass of water. Doses of 400 mg or 600 mg should be administered once daily, whereas a dose of 800 mg should be administered as 400 mg twice a day.
3. Imatinib Side effects:
The most common side effects include feeling sick (nausea), diarrhea, headaches, leg aches/cramps, fluid retention, visual disturbances, itchy rash, lowered resistance to infection, bruising or bleeding, loss of appetite;weight gain, reduced number of blood cells (neutropenia, thrombocytopenia, anemia), and edema. Although rare, restoration of hair color has been reported as well.
You may interested in:
| Other Hot-Selling Similar Product | |||
| Gefitinib | Lapatinib | AZD9291 | Lapatinib ditosylate |
| Dasatinib | Imatinib | Ibrutinib | Cabozantinib Malate |
| LOXO 195 | LOXO 101 | Fluconazole | Erlotinib Hydrochloride |
| baricitinib | ketoconazole | Niraparib | Niraparib tosylate monohydrate |
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}